Amy Belliveau

Amy Belliveau is a skilled project manager with extensive experience in the biopharmaceutical industry, currently serving as a Senior CMC Project Manager at Akebia Therapeutics since August 2022. Prior to this role, Amy held the position of CMC Project Manager at Leap Therapeutics from October 2020 to August 2022, and worked as a Client Program Manager at Thermo Fisher Scientific, focusing on Viral Vector Manufacturing Services. Additional experience includes various project management and scientific roles at GE Healthcare, where responsibilities encompassed cell and gene therapy, biomanufacturing services, and upstream process development. Earlier in the career, Amy worked at Amgen and Tedor Pharma in pilot scale operations and analytical support, respectively, after starting as a Microbiologist/QC Analyst at Polar Beverages. Amy holds a Master's degree in Project and Program Management from Northeastern University and a Bachelor of Applied Science in Biotechnology from the University of Rhode Island.